loading
Chemomab Therapeutics Ltd Adr stock is traded at $1.17, with a volume of 69,303. It is up +0.86% in the last 24 hours and down -8.59% over the past month. Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
See More
Previous Close:
$1.16
Open:
$1.17
24h Volume:
69,303
Relative Volume:
0.20
Market Cap:
$22.82M
Revenue:
-
Net Income/Loss:
$-33.08M
P/E Ratio:
-0.398
EPS:
-2.94
Net Cash Flow:
$-25.68M
1W Performance:
-3.31%
1M Performance:
-8.59%
6M Performance:
-25.95%
1Y Performance:
+77.30%
1-Day Range:
Value
$1.1001
$1.21
1-Week Range:
Value
$1.08
$1.22
52-Week Range:
Value
$0.603
$2.55

Chemomab Therapeutics Ltd Adr Stock (CMMB) Company Profile

Name
Name
Chemomab Therapeutics Ltd Adr
Name
Phone
972-77-331-0156
Name
Address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV
Name
Employee
16
Name
Twitter
Name
Next Earnings Date
2024-11-14
Name
Latest SEC Filings
Name
CMMB's Discussions on Twitter

Compare CMMB with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CMMB
Chemomab Therapeutics Ltd Adr
1.17 22.82M 0 -33.08M -25.68M -2.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.47 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.49 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.87 36.96B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.75 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
252.77 25.74B 3.81B -644.79M -669.77M -6.24

Chemomab Therapeutics Ltd Adr Stock (CMMB) Upgrades & Downgrades

Date Action Analyst Rating Change
May-13-24 Initiated Maxim Group Buy
May-06-24 Upgrade Oppenheimer Perform → Outperform
Dec-19-23 Resumed ROTH MKM Buy

Chemomab Therapeutics Ltd Adr Stock (CMMB) Latest News

pulisher
Mar 27, 2025

The Aurora Cannabis Inc (NASDAQ: ACB) Stock Price: Is It Overvalued? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

How Stable And Growing Is Globavend Holdings Ltd (NASDAQ: GVH)? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Before Buying AYRO Inc (NASDAQ: AYRO) Stock, Read This First - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Is Advance Auto Parts Inc (NYSE: AAP) A Good Investment For New Investors Now? - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

Nu Holdings Ltd (NYSE: NU) Has Great Upside Potential - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

ZEEKR Intelligent Technology Holding Ltd. ADR (NYSE: ZK): Getting A Free Pass? - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

AT&T, Inc (NYSE: T) Jumps 1.59%: What Could Be On The Way Going Forward? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Adma Biologics Inc (NASDAQ: ADMA): Blank Check For Growth? - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

A Bullish 2025 Outlook For Blink Charging Co (NASDAQ: BLNK) Shares - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

In 2025, Linkers Industries Ltd (NASDAQ: LNKS) Shares Will Likely Be Bullish - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Carrier Global Corp (NYSE: CARR): On Track To A Higher Share Price - Stocks Register

Mar 27, 2025
pulisher
Mar 27, 2025

Before Buying Avantor Inc (NYSE: AVTR) Stock, Read This First - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

Ally Financial Inc (NYSE: ALLY): An Enticing Stock To Watch - stocksregister.com

Mar 27, 2025
pulisher
Mar 27, 2025

Nebokitug shows promise in PSC treatment trial - Investing.com

Mar 27, 2025
pulisher
Mar 12, 2025

Does DLocal Limited (NASDAQ: DLO) Still Need To Convince Analysts? - stocksregister.com

Mar 12, 2025
pulisher
Mar 10, 2025

Think You Need A Good Stock? Look At This Scilex Holding Company (NASDAQ: SCLX) Analysis - stocksregister.com

Mar 10, 2025
pulisher
Mar 03, 2025

Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - stocksregister.com

Mar 03, 2025
pulisher
Feb 20, 2025

Chemomab Therapeutics (CMMB) Stock Price, News & Analysis - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

How analysts predict Chemomab Therapeutics Ltd ADR (CMMB) will perform this quarter? - US Post News

Feb 19, 2025
pulisher
Feb 19, 2025

Nebokitug positioned as potential first FDA-approved PSC treatment By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Jan 09, 2025

LogicMark Inc (LGMK) Recovers 0.71% From Low: Are We There Yet? - Stocks Register

Jan 09, 2025
pulisher
Nov 19, 2024

Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis - GlobeNewswire Inc.

Nov 19, 2024
pulisher
Nov 14, 2024

Chemomab Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update - Investing.com

Nov 14, 2024
pulisher
Oct 15, 2024

Chemomab reports progress in PSC treatment trial - Investing.com

Oct 15, 2024
pulisher
Feb 14, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 14, 2024
pulisher
Jan 13, 2023

Intercept (ICPT) Gains 12.4% in the Past Six Months: Here's Why - Zacks Investment Research

Jan 13, 2023
pulisher
Jun 17, 2021

What You Need To Know About Chemomab Therapeutics Ltd.'s (NASDAQ:CMMB) Investor Composition - Yahoo Finance

Jun 17, 2021
pulisher
Mar 23, 2021

CMMB News Today | Why did Chemomab Therapeutics stock go down today? - MarketBeat

Mar 23, 2021

Chemomab Therapeutics Ltd Adr Stock (CMMB) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.27
price up icon 1.00%
$71.24
price up icon 2.49%
$32.19
price up icon 0.00%
$27.35
price up icon 8.45%
$104.68
price up icon 2.82%
biotechnology ONC
$252.77
price up icon 10.27%
Cap:     |  Volume (24h):